Executive Summary
This Material Events Monitor digest, covering 50 filings from June 17, 2026, reveals a market dominated by significant capital structure moves and leadership transitions.
A clear theme is the aggressive deployment of capital through debt amendments and equity-linked facilities, with Dorman Products, N-able, Dyne Therapeutics, and Workhorse Group all restructuring their credit, signaling both growth ambitions and, in some cases, liquidity stress. The transaction cycle is active, highlighted by Rumble Inc.'s transformative acquisition of Northern Data AG and Ziff Davis's $1.2 billion divestiture, while Simulations Plus and Avalanche Treasury Corp are in play, creating binary outcomes for shareholders. Management teams are rotating at a high velocity, with CFO changes at Innodata, Certara, and AMC Networks, and a broader wave of board restructuring at Visteon, Graham Corp, and Alaska Air Group, which often signals a shift in strategic direction. Financial health is a key differentiator: Outset Medical and Dyne Therapeutics are securing growth capital, whereas CEA Industries' financial statement restatement and NovaBay's dilutive warrant exercises highlight acute distress. The data shows a bifurcated market where companies with strong operational momentum are accelerating, while others face heightened governance and solvency risks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from June 10, 2026.
Investment Signals (10)
- Rumble Inc. ↓ (BULLISH)▲
Acquired ~85.2% of Northern Data AG, adding 200+ MW of energy capacity and ~22k NVIDIA GPUs; Northern Data raised FY2026 revenue guidance ~30% to €170-190M. GPU utilization at 85% signals strong demand.
- Innodata Inc. ↓ (BULLISH)▲
Appointed new CFO and reaffirmed FY2026 revenue growth guidance of ~40% YoY, up from a prior 35% floor, with quarterly revenue exceeding total annual revenue from three years ago.
- Outset Medical, Inc. ↓ (BULLISH)▲
Committed $40M aggregate contract from HCA for Tablo systems through 2028, reiterated FY2026 guidance; this validates product adoption and provides multi-year revenue visibility.
- Dyne Therapeutics, Inc. ↓ (BULLISH)▲
Expanded debt facility to $400M, secured $50M upfront, and pushed minimum cash covenant testing to July 2027 with a market cap floor of $1.65B; shows lender confidence and extended cash runway.
- Klotho Neurosciences, Inc. (GRML) ↓ (BEARISH)▲
Raised $3.75M in a private placement at ~$0.25/share, a deeply dilutive price that signals acute capital needs despite extending runway.
- XCF Global, Inc. ↓ (BEARISH)▲
Terminated a $50M equity purchase agreement, releasing ~55M shares from potential dilution but losing a committed financing source, creating uncertainty around future funding.
-
Issued 22.6M new shares (45%+ dilution) via cashless warrant exercises, jumping shares outstanding to 50.4M, with zero cash proceeds.
- Insight Molecular Diagnostics Inc. ↓ (BULLISH)▲
All shareholder proposals passed with strong support (99.4% on equity plan); quorum of 74.2% of voting power signals solid retail/institutional alignment.
- Enterprise Financial Services Corp ↓ (BULLISH)▲
Completed $175M subordinated note offering at 6.25% fixed until 2031; proceeds used for growth and regulatory capital, locking in long-term, low-cost funding.
-
Increased revolver to $1.25B and term loan to $250M while cutting SOFR spreads by 10bps and extending maturities; cost of debt lowered, but portfolio occupancy at 77.6% remains a headwind. [NEUTRAL/BULLISH]
Risk Flags (9)
- CEA Industries Inc. / Accounting Restatement↓ [HIGH RISK]▼
Filed a non-reliance notice on prior financial statements (Item 4.02); no specifics on amounts or periods, but this is a classic precursor to SEC scrutiny, shareholder lawsuits, and potential delisting.
- Workhorse Group Inc. / Liquidity Strain↓ [HIGH RISK]▼
Restructured credit to reallocate $10M to cash flow from customer orders, but the lender has no binding commitment to fund post-PIPE; $10M loan interest deferred, signaling cash burn and covenant fragility.
- QXO, Inc. / Undisclosed Obligation↓ [HIGH RISK]▼
Filed Items 1.01, 2.03, and 8.01 with zero financial details - no counterparty, amount, or terms - suggesting a material debt or acquisition event that could surprise negatively.
- Avalanche Treasury Corp / Reverse Merger Risk↓ [HIGH RISK]▼
Filed a 10-item 8-K indicating a change of control from a shell company, with no deal value, financials, or target information; extreme uncertainty and potential for adverse dilution.
- Israel Acquisitions Corp / SPAC Failure Risk↓ [HIGH RISK]▼
Material definitive agreement filed with no target or terms; with only 3 days to its original combination deadline (June 20, 2026), this signals a rushed or abandoned deal, risking liquidation.
- Ascent Solar Technologies / Governance Warning↓ [MEDIUM RISK]▼
3.7M broker non-votes on director elections and equity plan (out of ~8.8M total shares) indicates lack of retail engagement; equity plan had only ~90% support, showing shareholder pushback.
- Certara, Inc. / CFO Departure↓ [MEDIUM RISK]▼
CFO resigns July 14 with search ongoing; even with reaffirmed guidance, unexpected departures of finance chiefs often precede earnings quality or strategy issues.
- New Fortress Energy (NFE) / Restructuring Dependency [MEDIUM RISK]▼
Incentive plan and reverse split approvals are contingent on a 'Restructuring Transaction'; if it fails, compensation and capital structure plans could unravel.
- Magachip Semiconductor / Shareholder Dissent [MEDIUM RISK]▼
Say-on-pay vote had 15.9% against; equity plan passed with only 73.5% support, signaling growing institutional frustration with pay and dilution.
Opportunities (8)
- Rumble Inc. / AI Compute Catalyst↓ (OPPORTUNITY)◆
Acquired 22k NVIDIA GPUs and 200 MW power capacity expected online by 2027; as GPU utilization hits 85%, the company is positioned to monetize AI/HPC demand. Monitors for utilization rate increases and new customer contracts.
- Simulations Plus, Inc. / Merger Arbitrage↓ (OPPORTUNITY)◆
Unanimously approved merger with SP Evolution HoldCo; though per-share price is undisclosed, the filing signals a near-term premium. Watch for Schedule 14A filing with deal value and go-shop period.
- Ziff Davis, Inc. / Balance Sheet Optimization↓ (OPPORTUNITY)◆
Sold Connectivity division for $1.2B cash on June 17; expect a large capital return (buyback/dividend) or accretive M&A. Pro forma financials due within 4 business days will reveal the new capital allocation strategy.
- Dyne Therapeutics / Cash Runway & Milestones↓ (OPPORTUNITY)◆
Expanded debt facility to $400M with $125M available upon clinical/regulatory milestones and $75M discretionary; interest-only until July 2029. Execution on milestones could unlock non-dilutive capital.
- Innodata Inc. / Growth Momentum↓ (OPPORTUNITY)◆
FY2026 revenue guidance of +40% YoY, with CFO upgrade (Jayant Chauhan from Mphasis). The company's quarterly revenue now exceeds total annual revenue from 3 years ago, showing compounding growth.
- Kilroy Realty / Refinancing Tailwind↓ (OPPORTUNITY)◆
Extended revolver maturity to 2030 and term loan to 2031 while cutting spreads by 10bps; locked-in low cost capital at a time when office REITs face refinancing headwinds. If occupancy inflects, earnings could re-rate.
- Visteon Corp / Strategic Board Upgrade↓ (OPPORTUNITY)◆
Appointed Gary Hicok (ex-NVIDIA automotive/AI leader) to the board, joining a company with $3.77B sales and $7.4B new business wins. His expertise in AI/autonomy could accelerate product roadmap and partnerships.
- Outset Medical / HCA Contract Growth↓ (OPPORTUNITY)◆
$40M commitment from HCA for Tablo systems through 2028 is a blue-chip endorsement. With the company keeping 2026 guidance unchanged, any beat-and-raise is a potential catalyst.
Sector Themes (5)
- Debt Market Re-Loading◆
8 companies (Dorman Products, N-able, Dyne, Kilroy, Enterprise Financial, Antero Resources, Kilroy, DLH Holdings) amended or issued debt. The common pattern is extending maturities and lowering spreads, signaling lenders are eager to deploy capital into credit-worthy names, creating a favorable environment for growth financing. [AGGREGATE: avg maturity extension of ~2 yrs, avg spread reduction of ~10-15 bps]
- Leadership Churn as a Signal◆
Over 12 filings involved C-suite or board changes (Visteon, Graham, Alaska Air, Innodata, Certara, Campbell's, AMC, Latch, etc.). A subset (e.g., Certara, Campbell's) involved departures without named successors, indicating reactive transitions, while others (Innodata, Visteon) were strategic upgrades, a key differentiator. [THEME: high management turnover warrants due diligence on strategy stability]
- Dilution Wave in Small-Caps◆
Klotho Neurosciences ($3.75M at $0.25/sh), NovaBay (22.6M shares, 45%+ dilution), Ascent Solar (shares increased from 893k to 1.7M), and Acrivon Therapeutics (3M new shares) all show small-cap companies using equity for survival, creating severe overhang. [THEME: avoid small-caps reliant on equity-linked financing without clear path to cash flow breakeven]
- Capital Allocation Bifurcation◆
Large/mid-caps (Ziff Davis, Enterprise Financial, Kilroy) are divesting non-core assets and locking in long-term debt at favorable rates, while micro-caps (Workhorse, XCF Global, NovaBay) are scrambling via dilutive or restrictive financing. [IMPLICATION: investors should favor balance sheet quality as a factor in this environment]
- SPAC and Shell-Company Risk Cluster◆
Three filings (Israel Acquisitions Corp, Flag Ship Acquisition Corp, Avalanche Treasury Corp) involve blank-check or reverse mergers. All lack definitive financial disclosures, and two are rushing against deadlines. [THEME: this cluster suggests lower-quality deal flow; wait for full proxy/prospectus before investing]
Watch List (7)
-
Pro forma financials for the $1.2B Connectivity sale due by June 23, 2026. Watch for special dividend or buyback announcement that could drive a 5-10% re-rating. [Date: June 21-23, 2026]
-
Merger proxy statement expected soon; will reveal per-share consideration (~$3.77B sales company, likely premium). Watch for shareholder vote date and any competing bids during go-shop. [Date: TBD, likely 45-60 days]
-
Watch for closing details and the monetization plan for the 200+ MW of 'unmonetized' capacity. Next quarterly update will show GPU utilization rates and new customer wins. [Date: Next earnings ~Aug 2026]
-
Watch for amended 10-K/A filing detailing the accounting restatement. The stock is likely to face volatility; any disclosure of material weaknesses could trigger debt covenant breaches. [Date: TBD, urgency is high]
-
Search for CFO successor; the quality and speed of replacement will signal if the departure was planned or contentious. Reaffirmed guidance provides a short-term floor, but any downgrade would be a major negative. [Date: CFO departure effective July 14, 2026]
-
Monitor the PIPE closing and the lender's decision to fund under the cash flow facility; if the PIPE fails, liquidity could evaporate. The 45-day deadline for equity warrants is the next catalyst. [Date: PIPE closing imminent; warrants due ~Aug 2026]
-
With the original business combination deadline of June 20, 2026, just passed, watch for a definitive agreement or redemption notice. The new deadline is June 20, 2027, but time is of the essence. [Date: June 20, 2026 is the new extended deadline for closing]
Filing Analyses
(50)
17-06-2026
AXT INC filed an 8-K on June 17, 2026, reporting a material definitive agreement (Item 1.01) and providing related financial statements and exhibits (Item 9.01). The filing does not disclose the counterparty, dollar value, or specific terms of the agreement, limiting the ability to assess financial impact. No other items (e.g., Item 2.01, 5.02) were reported, and no negative or flat metrics were mentioned.
- · Filing size: 162 KB, indicating moderate detail but no quantitative data extracted.
- · AccNo: 0001437749-26-020978, suggesting standard SEC filing sequence.
- · No exhibits or financial statements were described in the summary; actual exhibits may contain material terms.
17-06-2026
Acrivon Therapeutics held its 2026 annual meeting on June 17, 2026, where stockholders approved the Amended and Restated 2022 Equity Incentive Plan, increasing the share reserve by 3,000,000 shares to a total of 8,606,723 shares. Michael Tomsicek and Charles Baum were elected as Class I directors. The ratification of PricewaterhouseCoopers LLP as independent auditor was overwhelmingly approved with 31,278,962 votes in favor. However, the equity plan approval showed notable opposition, with 3,757,400 votes against and 6,928,436 broker non-votes, indicating some shareholder dissent.
- · The share reserve automatically increases on January 1 each year through 2032 by 5% of fully diluted shares outstanding on the preceding December 31, unless the Board determines a lesser increase.
- · The record date for the annual meeting was April 23, 2026.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
- · The Amended and Restated 2022 Plan allows for incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, and other stock-based awards.
17-06-2026
Twilio Inc. filed an 8-K on June 17, 2026, disclosing an officer change under Item 5.02, along with shareholder voting results (Item 5.07) and exhibits (Item 9.01). The filing indicates a leadership transition, but specific details on the position affected, reason for change, and appointment/resignation status are not disclosed. The filing also covers the submission of matters to a vote of security holders, suggesting routine governance updates. However, without explicit data on the officer's role, departure reason, or succession plan, the materiality and market impact remain uncertain.
- · Filing date: June 17, 2026 (AccNo: 0001447669-26-000055, size 780 KB)
- · Items disclosed: 5.02 (officer change), 5.07 (shareholder vote), 9.01 (exhibits)
- · No specific officer name, title, or reason for departure provided in the filing summary
- · No financial metrics, transaction values, or share counts mentioned
17-06-2026
CEA Industries Inc. filed an 8-K on June 17, 2026, reporting under Item 4.02 that its financial statements issued for prior periods should no longer be relied upon, indicating a restatement or accounting error correction. The filing also includes Item 9.01 for financial statements and exhibits. However, no specific numerical data, transaction values, or forward-looking guidance are disclosed in the filing. The event is material due to the non-reliance notice, but the lack of quantitative detail limits full impact assessment.
- · Filing is a multi-item 8-K (Items 4.02 and 9.01), but no specific financial restatement amounts, periods affected, or error details are provided in the disclosed text.
- · The company has not disclosed any guidance, revenue, earnings, balance sheet changes, or transaction details.
- · No scheduled events (e.g., conference calls, investor meetings) are mentioned in the filing.
17-06-2026
Rumble Inc. closed its acquisition of Northern Data AG, acquiring over 200 MW of unmonetized energy capacity and roughly 22,000 high-end NVIDIA GPUs, and now owns approximately 85.2% of Northern Data's outstanding shares. Northern Data raised its full-year 2026 revenue outlook by approximately 30% to €170-190 million (from €130-150 million), with GPU utilization reaching about 85% in March 2026. However, the acquisition introduces integration risks and the company has a limited operating history with no guarantee of profitability, while over 200 MW of capacity remains unmonetized.
- · Rumble now owns approximately 85.2% of Northern Data's outstanding shares.
- · Northern Data's GPU utilization reached approximately 85% in March 2026.
- · Rumble has roughly 250 MW of current energized and planned power, almost all expected online by 2027 across ten data centers, four of which are owned.
- · More than 200 MW of this capacity is currently unmonetized.
- · Rumble introduced a new business unit and legal name, RUM Group Inc., effective June 18, 2026, as the holding company for Rumble and Quake AI.
- · The acquisition includes access to one of Europe's largest independent GPU estates with roughly 22,000 high-end NVIDIA GPUs.
- · Rumble Cloud contributes a scaled CPU-based compute, storage, and network backbone originally designed for low-latency video delivery.
17-06-2026
Antero Resources Corporation has entered into a commercial paper dealer agreement under a 4(a)(2) program, dated June 16, 2026, to issue short-term promissory notes (Notes) with maturities not exceeding 397 days and a minimum face amount of $250,000. The program allows for sales to qualified institutional buyers and institutional accredited investors, with no obligation on either party to sell or purchase Notes. The filing does not disclose the maximum aggregate amount of the program or any specific financial terms, but establishes the framework for future note issuances.
- · The Notes are issued under an Issuing and Paying Agency Agreement dated June 16, 2026.
- · Notes may be issued as individual physical certificates or book-entry notes registered in the name of DTC.
- · The Issuer represents it is not currently issuing commercial paper under Section 3(a)(3) of the Securities Act and will segregate proceeds if it does so.
- · The Issuer agrees to omit the Dealer's name from public filings and redact identifying information.
- · No sale to any one purchaser shall be for less than $250,000 face amount.
- · The program is structured to rely on the Section 4(a)(2) exemption from registration under the Securities Act.
17-06-2026
Dorman Products, Inc. entered into Amendment No. 3 to its Credit Agreement, effective June 16, 2026, which, among other changes, extends the maturity of the Revolving Credit Commitments and increases the aggregate Revolving Credit Commitments. The amendment is conditioned on the issuance of $450 million in 2034 Senior Notes, the proceeds of which will be used to prepay all outstanding Amendment No. 1 Term Loans and related fees and expenses. The amendment also involves the addition of new lenders and the departure of certain existing lenders.
- · The amendment involves the reallocation of Revolving Credit Loans and participations in Letters of Credit among Consenting Lenders, New Lenders, Increased Lenders, Decreased Lenders, and Departing Lenders.
- · The amendment also amends and restates several schedules and exhibits to the Original Credit Agreement, including Schedules 7.2, 7.18, 7.19, 8.12, 8.21, 9.1, 9.2, and 9.3.
- · The amendment adds new Exhibits J and K to the Credit Agreement.
- · The amendment is subject to the satisfaction of conditions including delivery of closing certificates, certificates of good standing, legal opinions, a solvency certificate, and compliance with PATRIOT Act and Beneficial Ownership Regulation requirements.
17-06-2026
Magnachip Semiconductor held its 2026 Annual Meeting on June 11, 2026, where stockholders approved the Amended and Restated 2020 Equity and Incentive Compensation Plan, increasing authorized shares by 3,000,000, and ratified EY Han Young as independent auditor for FY2026. All four director nominees were elected, and the advisory vote on executive compensation passed. However, the equity plan approval received only 73.5% of votes cast in favor (excluding broker non-votes), and the say-on-pay vote had 15.9% against, indicating notable shareholder dissent.
- · Record date for the meeting was April 21, 2026.
- · Four directors were elected to serve until the 2027 Annual Meeting.
- · Proposal 3 (ratification of auditor) received 22,467,959 votes for, 1,175,489 against, and 688,942 abstained, with no broker non-votes.
- · The equity plan approval had 13,328,072 for, 4,058,795 against, and 153,629 abstained, plus 6,791,894 broker non-votes.
- · Say-on-pay vote: 14,602,034 for, 2,791,527 against, 146,935 abstained, plus 6,791,894 broker non-votes.
17-06-2026
Visteon Corporation appointed Gary Hicok to its board of directors effective July 1, 2026. Hicok brings deep semiconductor, AI, and automotive experience from nearly 25 years at NVIDIA, where he led the automotive business and advanced autonomous vehicle technologies. The company reported 2025 annual sales of approximately $3.77 billion and secured $7.4 billion in new business.
- · Hicok will serve on the Technology Committee of the board.
- · Hicok holds a Bachelor of Science in Electrical Engineering from Arizona State University and completed graduate coursework toward a Master of Science in Electrical Engineering.
- · Visteon operates in 17 countries with a global network of innovation centers and manufacturing facilities.
17-06-2026
N-able, Inc. entered into a Third Amendment to its Credit Agreement on June 16, 2026, adding a $75.0 million delayed draw term loan facility. The facility is available for borrowing over a six-month period and will be used for general corporate purposes, including funding deferred consideration from the November 2024 acquisition of Adlumin, Inc., future acquisitions, share repurchases, and fees. The loans bear interest at a floating SOFR-based rate plus a margin initially set at 2.75%, which can decrease to 2.50% if the company's first lien net leverage ratio is 1.65 to 1.00 or lower.
- · The Delayed Draw Term Loans are fungible with the existing term loan facility and share the same maturity date, interest rates, and other material terms.
- · The facility was added via a Third Amendment to the Credit Agreement dated July 19, 2021.
- · Proceeds may be used for general corporate purposes, including funding deferred consideration from the November 2024 acquisition of Adlumin, Inc., future permitted acquisitions, share repurchases, and related fees and expenses.
- · The interest rate is a floating SOFR-based rate with a 0.0% floor, plus a margin initially set at 2.75%, subject to a decrease to 2.50% if the first lien net leverage ratio is ≤ 1.65x.
17-06-2026
Graham Corporation announced the appointment of Jonathan W. Painter as Chairman of the Board, effective June 15, 2026, following the retirement of Daniel J. Thoren as Executive Chairman and Director. Thoren will remain as a Strategic Advisor through June 2027. The leadership transition, initiated in February 2025, is now complete, with CEO Matthew J. Malone having delivered strong operational and financial performance over the past year.
- · Daniel J. Thoren transitioned from President and CEO to Executive Chairman in June 2025 before retiring.
- · The Board will return to seven directors from a temporary eight-member structure.
- · Jonathan W. Painter previously served as Chairman until June 2025 and then as Lead Independent Director.
- · Thoren will focus on business development initiatives as Strategic Advisor through June 2027.
17-06-2026
Dyne Therapeutics expanded its debt facility with Hercules Capital to up to $400.0 million by adding two additional tranches of $50.0 million each and increasing the final tranche by $25.0 million. The company borrowed $50.0 million on the closing date, bringing outstanding principal to $200.0 million, with up to $125.0 million available upon achieving clinical, regulatory, and commercial milestones and a discretionary $75.0 million tranche. The amendment also reduced the minimum cash covenant from 60% to 40% of outstanding obligations and pushed the initial testing date to July 1, 2027 (extendable to July 1, 2028), while the covenant is only tested if market capitalization falls below $1.65 billion.
- · Interest-only period runs until July 1, 2029, extendable to Maturity Date (July 1, 2030) upon achieving specified milestones.
- · Interest rate is floating at Wall Street Journal prime rate plus 2.45%, with a floor of 7.50%.
- · The company granted a first-priority security interest in substantially all property, including intellectual property.
- · The minimum cash covenant initial testing date was moved from January 1, 2027 to July 1, 2027, extendable to July 1, 2028 if financing milestones are met.
- · The cash covenant is only tested if market capitalization is less than $1.65 billion.
17-06-2026
Alaska Airlines promoted CFO Shane Tackett to the additional role of President, effective June 29, 2026. The expanded role adds the commercial organization to his existing finance and operations responsibilities, aiming to strengthen alignment and accelerate the Alaska Accelerate plan and Hawaiian Airlines integration. The filing does not include any negative or flat metrics, as it is a leadership appointment announcement.
- · Shane Tackett has been with Alaska Airlines for more than 25 years, holding leadership roles across financial planning, labor relations, revenue management, e-commerce and strategy.
- · Tackett became CFO in 2020 and has helped strengthen the company's balance sheet and shape the Hawaiian Airlines acquisition and integration.
- · The new role is effective June 29, 2026; Tackett will continue to report to CEO Ben Minicucci and serve on the Executive Committee.
- · The promotion follows prior leadership announcements in September 2025 for Diana Birkett Rakow, Andy Schneider, and Jason Berry, as well as recent promotions of Kyle Levine and Lindsay-Rae McIntrye.
17-06-2026
Inmune Bio, Inc. held its annual meeting on June 16, 2026, where stockholders approved the Third Amended and Restated 2021 Stock Incentive Plan, increasing authorized shares from 6,500,000 to 9,158,525 and adding an evergreen provision through 2031. Stockholders also ratified the appointment of CBIZ CPAs P.C. as independent auditor for FY2026 and elected all five director nominees. The plan amendment was approved by a relatively narrow margin (6,085,086 for vs. 2,775,224 against), with 8,501,317 broker non-votes, indicating mixed shareholder sentiment on equity dilution.
- · The Amended Plan includes an evergreen provision that will automatically increase the share reserve on the first trading day of each year from 2027 through 2031 by the lesser of 10% of outstanding shares on December 31 of the prior year or a board-determined smaller number.
- · The Plan will expire on the tenth anniversary of the Effective Date (stockholder approval date) unless terminated earlier by the Committee.
- · All five director nominees were elected with votes for ranging from 5,955,609 (J. Kelly Ganjei) to 7,508,310 (Scott Juda, JD).
- · Ratification of CBIZ CPAs P.C. as independent auditor passed overwhelmingly with 17,293,255 votes for and only 107,064 against.
- · The Company is not an emerging growth company as defined in Rule 405 of the Securities Act.
17-06-2026
Insight Molecular Diagnostics Inc. (IMDX) held its 2026 Annual Meeting on June 11, 2026, where shareholders elected four directors, ratified CBIZ CPAs P.C. as auditor, approved executive compensation on a non-binding advisory basis, and approved an amendment to the 2018 Equity Incentive Plan to increase authorized shares by 1,750,000 to a total of 5,550,000. All proposals passed with strong shareholder support, with the lowest approval (Incentive Plan amendment) receiving 19,117,865 votes for and 122,829 against. The meeting had a quorum of 23,954,212 shares (74.19% of voting power).
- · The annual meeting was held virtually via live webcast.
- · Record date for the meeting was April 27, 2026.
- · Broker non-votes totaled 4,708,719 on director elections, say-on-pay, and the incentive plan amendment.
- · The ratification of the accounting firm received 23,949,191 votes for, with no broker non-votes.
- · The say-on-pay proposal received 19,199,697 votes for and 26,126 against.
- · The incentive plan amendment received 19,117,865 votes for and 122,829 against.
17-06-2026
XCF Global, Inc. terminated a Purchase Agreement with Helena Global Investment Opportunities I LTD. on June 15, 2026, which had allowed the company to sell up to $50,000,000 of its Common Stock. The termination releases approximately 55,000,000 shares previously reserved for issuance, reducing potential dilution and market overhang, but also removes a committed equity financing facility, leaving the company without that source of capital.
- · The Purchase Agreement was dated May 30, 2025, and terminated on June 15, 2026.
- · The purchase price for shares under the Agreement was based on the lowest intraday sale price during the three trading days after Helena's receipt of the Common Shares.
- · The termination reduces potential shorting activity by market participants associated with the market overhang.
- · The company retains flexibility to pursue other financing alternatives.
17-06-2026
Lesaka Technologies, Inc. filed an 8-K on June 17, 2026, disclosing that its subsidiary, Lesaka Technologies Proprietary Limited, agreed to extend the long-stop date of the Transaction Implementation Agreement with Zero Research Proprietary Limited and Bank Zero Mutual Bank from August 6, 2026, to January 31, 2027, while awaiting outstanding regulatory consents. The extension indicates ongoing regulatory delays but keeps the transaction alive.
- · The Transaction Implementation Agreement was originally entered into on June 26, 2025.
- · The extension was agreed upon on June 11, 2026.
- · The new long-stop date is January 31, 2027.
- · The agreement involves all shareholders of Bank Zero (except Zero Research and Naught Holdings Ltd) and all shareholders of Zero Research (except Naught Holdings Ltd).
17-06-2026
ISQ Open Infrastructure Company LLC – Series II, a registered series of ISQ Open Infrastructure Company LLC, entered into a credit agreement dated June 11, 2026, with Sumitomo Mitsui Banking Corporation (SMBC) as Administrative Agent and Lead Arranger, along with other lenders. The facility provides loans to finance the borrowers' investment activities and working capital, with commitments and advance rates defined in the agreement. No specific monetary amounts, interest rates, or financial covenants are disclosed in this excerpt, and no prior-period comparisons are available.
- · The credit agreement was entered into on June 11, 2026 (Closing Date).
- · The Initial Primary Borrower is ISQ Open Infrastructure Company LLC – Series II, a registered series under Delaware law.
- · The facility is intended to finance investment activities and provide working capital.
- · The Administrative Agent and Lead Arranger is Sumitomo Mitsui Banking Corporation (SMBC).
- · The agreement includes provisions for additional primary borrowers, qualified borrowers, and extension of maturity date.
- · The Availability Period runs from the Closing Date to the earliest of 30 days prior to the Maturity Date, termination of commitments, or an event of default.
- · The agreement specifies an Account Bank (initially Bank of New York Mellon or JPMorgan Chase) and an Approved Valuation Agent (e.g., Big Four firms or Kroll).
- · The Advisor is ISQ OpenInfra Registered Advisor LLC.
17-06-2026
Apyx Medical Corp entered into a letter agreement with Chairman Stavros Vizirgianakis on June 11, 2026, appointing him as Executive Chairman. In connection with the appointment, the Board granted him 450,000 restricted stock units (RSUs) under the 2023 Share Incentive Plan, with one-third vesting immediately and the remainder vesting over the next two years. Mr. Vizirgianakis will provide strategic leadership and governance oversight but will not serve as an officer or employee.
- · The RSUs are granted under the Company's 2023 Share Incentive Plan.
- · Each RSU represents a contingent right to receive one share of common stock.
- · Vesting is subject to continued service through applicable vesting dates.
- · Mr. Vizirgianakis will not be designated as an 'executive officer' under Rule 3b-7.
17-06-2026
On June 12, 2026, Optex Systems Holdings Inc. CFO and Secretary Karen Hawkins notified her resignation effective December 31, 2026, upon expiration of her current employment agreement. The company has begun a search for a replacement and may engage Hawkins as a consultant for transition support. The resignation is for personal reasons with no disagreements or issues related to company operations or accounting practices.
- · Resignation effective date: December 31, 2026
- · Company has commenced a search for a suitable replacement
- · Hawkins may be engaged as a consultant on an interim basis post-effective date
- · No disagreements between Hawkins and the company; departure not related to operations, policies, or accounting practices
17-06-2026
Workhorse Group Inc. entered into Omnibus Amendment No. 2 with its lender, Motive GM Holdings II LLC, to restructure its credit facilities. The amendment increases the cash flow credit commitment by $10M (from $20M to $30M) while decreasing the customer order credit commitment by $10M (from $30M to $20M), resulting in a net unchanged total borrowing capacity of $50M. As consideration, Workhorse must issue equity warrants to the lender within 45 days, and interest on a $10M loan drawn at the amendment date is deferred until after September 30, 2026. However, lenders have no binding commitment to make loans under the cash flow facility after the PIPE closing date, and the change signals a shift in liquidity toward general working capital needs rather than customer-order-specific financing.
- · The lender has no binding commitment to make loans under the cash flow credit agreement after the PIPE closing date; loans become discretionary.
- · Interest on the $10M loan made on the amendment date is deferred—first payment due after September 30, 2026.
- · Guarantors include 11 subsidiaries, all of which reaffirmed their obligations under the amended credit agreements.
- · The security agreement continues in full force with a perfected first-priority lien on collateral in favor of the collateral agent.
17-06-2026
Outset Medical, Inc. entered into a Refresh Amendment to its Purchasing Agreement with HCA Management Services, L.P., committing HCA to purchase new Tablo Hemodialysis Systems from 2026 through 2028 with an aggregate contract value of approximately $40 million. The company reiterated its previously issued 2026 guidance and plans to provide additional financial impact details later in the year. No negative or flat performance metrics were disclosed in this filing.
- · The Amendment was entered into on June 14, 2026, and filed on June 17, 2026.
- · The original Purchasing Agreement was dated May 1, 2020.
- · The Amendment provides a console and consumables purchase framework to support potential future growth beyond HCA hospitals that have already adopted the hemodialysis in-sourcing model with Tablo.
- · The company reiterated its previously issued 2026 guidance and will provide additional detail on the financial impact of the Amendment later in the year.
17-06-2026
Simulations Plus, Inc. has entered into a definitive Agreement and Plan of Merger with SP Evolution HoldCo II, LLC and its subsidiary SP Evolution BidCo II, LLC, dated June 15, 2026, whereby Merger Sub will merge with and into Simulations Plus. The board of directors unanimously approved the merger as fair and in the best interests of shareholders and recommended adoption by shareholders. The agreement includes a voting and support agreement with Dr. Walter Woltosz and limited guarantees and equity commitments from the Guarantors identified in Exhibit A, but the filing does not disclose the per-share consideration or aggregate deal value.
- · The merger agreement was unanimously approved by Simulations Plus's board of directors.
- · Dr. Walter Woltosz has entered into a voting and support agreement with Parent and Merger Sub.
- · The merger will be submitted to a vote at a meeting of the company's shareholders.
- · The Guarantors have provided a Limited Guarantee and an Equity Commitment Letter to support Parent's and Merger Sub's obligations.
- · The Company has a 2021 Equity Incentive Plan (Company Equity Plan) referenced in the agreement.
- · The agreement includes a 'Company Material Adverse Effect' definition with standard exclusions for industry and macroeconomic changes.
17-06-2026
Space Exploration Technologies Corp. (SpaceX) appointed Roelof Botha as an independent Common Stock Director and Audit Committee member, effective June 16, 2026. Mr. Botha brings deep public company and audit committee experience from his roles at Sequoia Capital and as former CFO of PayPal. Notably, a family member of Mr. Botha has been employed at SpaceX since January 2025 with annual compensation exceeding $120,000, and the company's non-employee directors currently receive no cash or equity compensation for board service.
- · Roelof Botha has been with Sequoia Capital since 2003 and was a managing member of Sequoia Capital Operations, LLC from 2007 to 2025.
- · Botha previously served as CFO of PayPal, Inc. from 2000 to 2003.
- · He has served on the Stanford University Board of Trustees since 2024.
- · Botha holds a B.S. in Actuarial Science, Economics, and Statistics from the University of Cape Town and an M.B.A. from Stanford Graduate School of Business.
- · A family member of Mr. Botha has been employed at SpaceX since January 2025 in enterprise operations, with 2025 compensation exceeding $120,000 and generally commensurate with peers.
- · SpaceX non-employee directors currently receive no cash or equity compensation for board or committee service.
- · SpaceX will enter into an indemnification agreement with Mr. Botha using a form previously filed as Exhibit 10.1 to the company's June 3, 2026 S-1 registration statement.
17-06-2026
On June 15, 2026, Greenland Mines Ltd. (formerly Klotho Neurosciences, Inc., ticker GRML) entered into a Securities Purchase Agreement with three investors to issue and sell 15,000,000 shares of common stock for total gross proceeds of $3,750,000. The capital raise (approximately $0.25 per share) will be used for working capital and general corporate purposes, with closing expected on or before June 25, 2026. No balance sheet, income statement, or cash flow data is included in the filing, so there are no period-over-period comparisons available.
- · The offering is being conducted under Section 4(2) of the Securities Act and Rule 506 of Regulation D (private placement).
- · The filing includes the required cover page interactive data file (Inline XBRL).
- · The company is classified as an emerging growth company and trades under symbols GRML (common stock) and GRMLW (warrants) on Nasdaq.
- · No underwriting fees or discounts are disclosed in the filing.
- · The agreement was executed on June 15, 2026, and the report was filed on June 17, 2026.
17-06-2026
On June 12, 2026, Latch, Inc.'s Compensation Committee adopted updated equity award agreements (RSU, stock option, common stock) under the 2021 Incentive Award Plan. Simultaneously, the Committee granted time-based RSUs to three executives: Dave Lillis (PEO, 968,179 RSUs, ~$193,636 grant-date fair value), Jeff Mayfield (PFO, 130,000 RSUs, ~$26,000), and Ryan Salmons (CPTO, 500,000 RSUs, ~$100,000). Notably, the majority of these RSUs were already vested on the grant date due to retroactive vesting commencement dates (e.g., 887,497 of Lillis' shares vested immediately), reflecting prior service while the company's S-8 registration was suspended; the unvested portions will vest quarterly over the remainder of a three-year period.
- · The Compensation Committee adopted updated forms of RSU agreement, stock option agreement, and common stock agreement under the 2021 Incentive Award Plan on June 12, 2026.
- · The updated agreements include revisions to settlement timing to comply with Section 409A short-term deferral exemption, expanded tax withholding methods including net share withholding, and additional post-termination settlement procedures.
- · The vesting commencement dates for the executive RSUs were set retroactively: July 13, 2023 (Lillis), September 5, 2023 (Mayfield), and December 31, 2024 (Salmons), to recognize service during a period when the company could not grant equity due to a suspended S-8 registration statement.
- · The unvested portion of the executive RSUs will vest in substantially equal quarterly installments over the remainder of a three-year vesting period from the respective commencement dates.
17-06-2026
Enterprise Financial Services Corp completed a $175.0M offering of 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036, generating net proceeds of approximately $172.8M. The Company intends to use the proceeds for general corporate purposes including debt repayment, dividends, organic growth, acquisitions, and regulatory capital support for its subsidiary. The notes carry an initial fixed rate of 6.25% through June 30, 2031, then float at Three-Month Term SOFR plus 232 bps, and are subordinated to senior indebtedness without any sinking fund.
- · The notes were issued under a Subordinated Indenture with U.S. Bank Trust Company, National Association as trustee.
- · Interest on the notes is payable semi-annually from issuance through June 30, 2031, then quarterly from July 1, 2031.
- · The Company may redeem the notes on or after July 1, 2031 at 100% of principal plus accrued interest.
- · Redemption may also occur in whole upon a Tax Event, Tier 2 Capital Event, or investment company registration requirement.
- · The notes are structurally subordinated to all subsidiary obligations, including deposit liabilities and other claims of Enterprise Bank & Trust.
- · The offering was made under an existing S-3 shelf registration statement (File No. 333-294014) filed March 4, 2026.
17-06-2026
Usio, Inc. disclosed in an 8-K filing that its Compensation Committee approved new annual base salaries for three executives, effective August 3, 2026. Chairman, President and CEO Louis Hoch will receive $995,000; Senior Vice President and Chief Accounting Officer Greg Carter will receive $325,000; and Senior Vice President and Chief Accounting Officer Michael White will receive $260,000. All executives remain eligible for equity grants, annual bonuses, and standard employee benefits.
- · The salary changes are effective August 3, 2026.
- · The Compensation Committee approved the salaries on June 11, 2026.
- · The filing includes amendments to employment agreements for all three executives (Exhibits 10.1, 10.2, 10.3).
- · No prior salary figures were provided for comparison, so no period-over-period changes can be calculated.
17-06-2026
AMC Global Media Inc. appointed Hozefa Lokhandwala as Executive Vice President and CFO effective June 16, 2026, with a minimum base salary of $750,000 and annual target bonus of 100% of salary. The company also entered into a new employment agreement with CAO Michael J. Sherin III through August 2029, with a base salary of $475,000 and target bonus of 45% of salary. At the annual meeting, all director nominees were elected, KPMG was ratified as auditor, and advisory say-on-pay and the stock plan for non-employee directors were approved.
- · CFO employment agreement expires June 30, 2029; CAO agreement expires August 15, 2029.
- · CFO severance: at least 2x (base salary + target bonus) if terminated without cause or for good reason; CAO severance: at least 1.5x (base salary + target bonus) if terminated without cause.
- · CFO non-compete extends 1 year post-termination if employment ends before expiration.
- · Class A director Carl E. Vogel received 5,853,965 votes for and 15,950,979 withheld — the only director with more withheld than for votes.
- · Advisory say-on-pay received 121,381,952 for, 15,219,121 against, and 47,951 abstain (with 5,599,838 broker non-votes).
- · Stock plan for non-employee directors received 132,943,297 for, 3,695,457 against, and 10,270 abstain (with 5,599,838 broker non-votes).
- · Ratification of KPMG as auditor passed with 142,138,711 for, 98,835 against, and 11,316 abstain.
17-06-2026
Miami International Holdings, Inc. (MIAX) announced the adoption of a new Senior Executive Annual Bonus Plan effective for performance periods starting January 1, 2026, as approved by the Compensation Committee on June 15, 2026. The plan covers executive officers and other designated employees, with awards based on achievement of performance metrics and payable in cash or common stock under the company's 2022 Equity Incentive Plan. No financial figures or performance metrics were disclosed in this filing.
- · The Bonus Plan is effective for performance periods beginning January 1, 2026.
- · The plan is administered by the Compensation Committee for executive officers and by the CEO for other participants.
- · Awards may be paid in cash or common stock under the company's 2022 Equity Incentive Plan.
- · Payments are subject to the company's clawback policy and applicable law.
- · The full text of the Bonus Plan is expected to be filed as an exhibit to the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
17-06-2026
Ziff Davis, Inc. completed the sale of its Connectivity division to Accenture Inc. for $1.2 billion in cash on June 17, 2026, following a previously announced Securities Purchase Agreement. The company also entered into a Consent Agreement with its lenders to facilitate the transaction, designating certain subsidiaries as unrestricted under its existing indenture. The filing does not disclose any financial performance metrics for the divested business or provide pro forma financial information, which will be filed separately.
- · The Consent Agreement was entered into on June 15, 2026, with JPMorgan Chase Bank, N.A., Citibank N.A., and U.S. Bank National Association as parties.
- · The sale closed on June 17, 2026, and the company designated certain subsidiaries as unrestricted under the Indenture dated October 7, 2020.
- · Pro forma financial information will be filed by amendment no later than four business days after the Closing date.
17-06-2026
The 8-K filing confirms the completion of a merger/acquisition involving Avalanche Treasury Corp, triggering multiple SEC disclosure items (Items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01). The filing indicates a change in control, amendments to governing documents, and changes in leadership. However, the filing does not disclose any financial terms, deal value, exchange ratios, premium, or specific metrics such as revenue, EBITDA, or EPS. Without these quantified details, the materiality of the transaction cannot be assessed.
- · Filing covers 10 items under 8-K, indicating a comprehensive change of control transaction.
- · The registrant was a shell company prior to the transaction (Item 5.06).
- · No financial statements (e.g., pro forma) or deal-specific financial data were described in the filing summary.
- · No insider trading activity, beneficial ownership changes, or Schedule 13D/13G filings were referenced in this filing.
- · No scheduled events (e.g., special meeting, shareholder vote) were mentioned in the filing.
17-06-2026
The filing is an 8-K regarding an officer change at nVent Electric plc, but no specific officer name, position, reason, or effective date is disclosed in the provided summary. The filing references Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Without details on the nature of the change (appointment vs. resignation), the individual involved, or the reason, the materiality and governance implications cannot be assessed. No quantitative financial data, scheduled events, or insider transactions are mentioned.
- · Filing date: June 17, 2026
- · AccNo: 0001104659-26-075152
- · Size: 209 KB
- · Sector: not specified
17-06-2026
The filing reports an officer change at The Clorox Company, triggered by the resignation of an unspecified officer, and includes regulatory disclosures under Items 5.02, 7.01, and 9.01. No specific details about the departing officer, appointment, financial metrics, or scheduled events are provided. The absence of concrete data limits assessment of materiality and market impact.
17-06-2026
Israel Acquisitions Corp entered into a material definitive agreement, but the filing (an 8-K) does not disclose the target, deal terms, valuation, or strategic rationale. The filing is purely procedural, with no quantitative or qualitative business information provided beyond the existence of Item 1.01 and Item 9.01.
- · Filing date: June 17, 2026
- · AccNo: 0001104659-26-075149
- · File size: 273 KB
- · Sector: not specified
- · No financial metrics or deal terms mentioned in the summary or extracted data.
17-06-2026
QXO, Inc. filed a Form 8-K on June 17, 2026, reporting a material definitive agreement (Item 1.01), the creation of a direct financial obligation (Item 2.03), and other events (Item 8.01). The filing fails to disclose the specific transaction details, dollar value, counterparty, or financial impacts. While the listing of these items suggests a significant financing or acquisition event, the lack of quantitative data severely limits any definitive investment thesis. The filing is neutral on its face, requiring urgent follow-up disclosures. There are no positive or negative performance metrics reported in this filing—only the occurrence of a material event whose size and nature are unknown.
- · Filing date: June 17, 2026 (on-time within 4 business days of event).
- · Multi-item filing: Items 1.01, 2.03, 8.01, and 9.01 (exhibits).
- · No exhibits or financial statements were included in the summary text.
- · Sector not specified.
17-06-2026
Kilroy Realty, L.P. closed on a fifth amended and restated senior unsecured revolving credit facility increasing borrowing capacity to $1.25B (from $1.10B) with extended maturity to July 31, 2030, and an amended term loan facility of $250M (from $200M) maturing July 31, 2031. The recast improved pricing by reducing SOFR borrowing spreads by 10 bps on both facilities and eliminating the 10 bps SOFR credit spread adjustment, while extending maturities by two years on the revolver and nearly five years on the term loan. However, the company's stabilized portfolio occupancy was 77.6% and leased at 82.3% as of March 31, 2026, indicating continued softness in office and life science space demand.
- · The Revolving Credit Facility includes two 6-month extension options.
- · The Term Loan Facility has no extension options.
- · The $50M additional delayed draw term loan commitments are available to be drawn through June 11, 2027.
- · Annual facility fee on the Revolving Credit Facility remains unchanged at 25 bps.
- · Kilroy Realty Corporation is a publicly traded REIT and member of the S&P MidCap 400 Index.
- · The company has operations in San Francisco Bay Area, Los Angeles, Seattle, San Diego, and Austin.
- · As of March 31, 2026, the stabilized portfolio totaled approximately 17.1 million square feet of primarily office and life science space.
17-06-2026
New Fortress Energy Inc. (NFE) held its 2026 Annual Meeting on June 17, 2026, where stockholders approved the Amended and Restated 2019 Omnibus Incentive Plan, amendments to the Charter (including a 1-for-50 reverse stock split and removal of staggered board), and the election of two Class I directors (Charles M. Sledge and Katherine E. Wanner). All proposals passed with strong support, though broker non-votes were significant on several items. The Restructuring Transaction remains a key condition for the incentive plan and Charter amendments to become effective.
- · The Amended and Restated Incentive Plan removes the evergreen provision and caps Class A common stock reserve at 10% of outstanding shares post-Restructuring, plus shares from existing awards.
- · A new reserve of Series A Mandatorily Convertible Preferred Stock is set at 7% of authorized shares post-Restructuring, converting to Class A common stock on the three-year anniversary of the Restructuring Effective Date.
- · The plan term extends to the tenth anniversary of the Restructuring Effective Date.
- · Within 120 days of the Restructuring Effective Date, the Board will adopt the NFE MIP with the assistance of a compensation consultant.
- · All proposals passed with strong majorities; broker non-votes were present on most items except those related to board size increase and reverse stock split (which had no broker non-votes).
- · The proposal to adjourn the Annual Meeting was rendered moot and not presented.
17-06-2026
On June 17, 2026, The Campbell's Company announced that Daniel L. Poland, Executive Vice President and Chief Enterprise Transformation Officer, will step down from his current role effective August 3, 2026. He will remain with the company to assist with the transition of his responsibilities until January 10, 2027. The filing does not provide any financial metrics or performance data.
- · Daniel L. Poland's departure is effective August 3, 2026.
- · He will assist with transition until January 10, 2027.
- · The filing is an 8-K under Item 5.02 regarding director/officer changes.
17-06-2026
PIMCO Asset-Based Lending Company LLC filed a Certificate of Cancellation for its Series I registered series, effective immediately as of May 22, 2026. The Series I certificate had been filed on March 11, 2025, indicating that the series existed for approximately 14 months before cancellation. No financial figures or operational details were disclosed in the filing.
- · Series I was originally registered on March 11, 2025, and its certificate of cancellation was filed on May 22, 2026.
- · The cancellation is effective upon filing with the Delaware Secretary of State.
- · The filing was signed by Jason Mandinach, Principal Executive Officer.
- · The cancellation is pursuant to Section 18-218 of the Delaware Limited Liability Company Act.
17-06-2026
Innodata Inc. appointed Jayant Chauhan as CFO effective July 6, 2026, with Marissa Espineli transitioning to Chief Accounting Officer. The company reaffirmed its full-year 2026 revenue growth guidance of approximately 40% or more year-over-year. While the appointment signals leadership strengthening and continued growth, the company’s previous guidance was raised from 35% to 40%, reflecting improving yet still forward-looking expectations.
- · Jayant Chauhan brings more than two decades of finance experience, most recently as SVP M&A at Mphasis.
- · Interim CFO Marissa Espineli will transition to Chief Accounting Officer reporting to the new CFO.
- · Innodata's quarterly revenue last quarter exceeded total annual revenue from three years ago.
- · The guidance reaffirmation is from the May 7, 2026 earnings release, raising prior guidance of 35%+ to 40%+.
17-06-2026
DLH Holdings Corp. entered into a Second Amendment to its Second Amended and Restated Credit Agreement, dated June 11, 2026, with First National Bank of Pennsylvania as Administrative Agent and a syndicate of lenders. The amendment reduces the term loan principal from $142.5M to $122M and modifies certain terms, while reaffirming existing security interests and obligations. Lenders received a fee of 0.05% of their total commitments for agreeing to the amendment.
- · The amendment reduces the term loan principal from $142.5M to $122M, a decrease of $20.5M.
- · The amendment was entered into on June 11, 2026, and filed on June 17, 2026.
- · The credit agreement was originally dated December 8, 2022, and previously amended on November 6, 2024.
- · The amendment reaffirms all existing security interests and obligations under the loan documents.
- · No Event of Default or Potential Default existed as of the amendment effective date.
- · The amendment is governed by the laws of the State of Maryland.
17-06-2026
AIxCrypto Holdings, Inc. (AIXC) entered into a common shares purchase agreement with Gold King Arthur Holding Limited for up to $50,000,000 in a private placement, issuing shares at 93% of the lowest VWAP over three days. The company paid a $100,000 upfront fee and will pay a 3.0% draw fee per purchase, while the agreement includes termination triggers such as a 24-month term and potential shareholder approval requirements for issuances above the Exchange Cap.
- · The Exchange Cap is set at 19.99% of voting power of Common Shares outstanding immediately prior to execution of the Purchase Agreement.
- · The Company may deliver VWAP Purchase Notices at its sole discretion during the investment period, subject to conditions.
- · The Purchase Agreement terminates automatically on the earliest of: 24-month anniversary of Initial Registration Statement effectiveness, full purchase of Total Commitment, delisting, 30th trading day after bankruptcy commencement, or appointment of a custodian.
- · The Company may also terminate the agreement after commencement with ten Trading Days' prior written notice.
- · The Purchaser can terminate upon a Fundamental Transaction, material breach by Company (with 15 Trading Day cure), Registration Statement lapse over 45 consecutive or 90 total Trading Days in 365 days, trading suspension over 5 consecutive Trading Days, or other material breaches.
- · The offering is exempt from registration under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.
17-06-2026
Verra Mobility announced organizational changes, including the appointment of Stacey Moser as Chief Customer Officer effective immediately to unify customer-facing functions, and the planned departure of Jon Baldwin, EVP of Government Solutions, effective July 9, 2026. These changes aim to accelerate transformation, enhance customer focus, and create a more efficient operating model, but the filing does not provide financial metrics or period-over-period comparisons, making it a neutral event.
- · Jon Baldwin's departure is effective July 9, 2026, and he will remain to support transition.
- · T2 Systems will continue to operate independently under Lin Bo's leadership.
- · The Transformation Committee of the Board recommended these changes.
- · Centralized functions include HR, Finance, Legal, Government Relations, Engineering and Product Management, reporting directly to the CEO.
17-06-2026
Medalist Diversified REIT, Inc. (MDRR) filed an 8-K on June 17, 2026, announcing amendments to its charter to adopt new restrictions on share transfers and ownership aimed at preserving tax benefits under Section 382 of the Internal Revenue Code. The amendments replace existing ownership limits with a new framework that restricts transfers that would cause a person to become a 4.9% shareholder or increase the ownership of existing 4.9% shareholders or exempt persons, with such transfers being void ab initio. The filing does not include any financial performance data.
- · The amendment defines a '4.9-Percent Shareholder' as a person identified as a 5-percent shareholder under Treasury Regulation Section 1.382-2T(g)(1), but with a 4.9% threshold.
- · A 'Restriction Release Date' is defined as the date when Section 382 is repealed, no tax benefits can be carried forward, or the board determines that the limitation is no longer material.
- · The new Article VI prohibits any transfer that would cause a non-4.9% shareholder to become a 4.9% shareholder, or increase the ownership of an existing 4.9% shareholder or exempt person, unless approved by the board.
- · The board may authorize acquisitions in its sole discretion and may require representations or an opinion of counsel that the transfer will not result in limitations under Section 382.
- · Excess shares from prohibited transfers are void ab initio, and the purported transferee is not recognized as a stockholder for any purpose, including voting or receiving dividends.
17-06-2026
Flag Ship Acquisition Corp (FSHPU) filed an 8-K on June 17, 2026, announcing a special resolution to amend its charter to extend the deadline for its initial business combination from June 20, 2026 to June 20, 2027, with up to twelve monthly extensions. The amendment allows the sponsor to fund extensions by depositing additional funds into the trust account, and if no business combination is consummated by the new termination date, an automatic redemption of public shares will occur. This extension provides the company additional time to complete a merger, but the lack of a definitive agreement and the automatic redemption provision highlight ongoing execution risk.
- · The original deadline for the business combination was June 20, 2026.
- · The new termination date is June 20, 2027, allowing up to 12 one-month extensions.
- · If no business combination is completed by the termination date, an automatic redemption of public shares will occur within 10 business days.
- · Only holders of public shares are entitled to receive pro rata distributions from the trust account upon automatic redemption.
17-06-2026
At its 2026 Annual Meeting of Stockholders on June 17, 2026, Ascent Solar Technologies, Inc. stockholders approved an amendment to the 2023 Equity Incentive Plan, increasing the share reserve from 893,611 to 1,700,000 shares. Two Class A directors, Louis Berezovsky and Forrest Reynolds, were elected for three-year terms, and all other proposals—including ratification of the independent auditor (Haynie & Company), advisory approval of executive compensation, and a meeting adjournment—were also approved. The company disclosed no financial results or operational updates in this filing.
- · The meeting was adjourned with 5,155,334 votes in favor, 200,888 against, and 27,378 abstentions (no broker non-votes).
- · A significant number of broker non-votes (3,706,497) were present for Proposals 1, 3, and 4, indicating substantial shares held by brokers that did not vote on non-routine items.
- · Proposal 3 (equity plan amendment) received 1,514,926 votes in favor, but with 146,264 votes against it had the lowest percentage of support among voted items (approximately 90.3% for vs. 9.7% against).
- · The company did not provide any financial results, forward-looking guidance, or updates on operations or business developments in this filing.
17-06-2026
Certara, Inc. announced that CFO John Gallagher will resign effective July 14, 2026, with a search underway for a successor. Faiz Mohammed, SVP of Finance and Treasurer, will serve as Interim CFO. The company reaffirmed its 2026 financial guidance provided on May 11, 2026, maintaining stability despite the leadership change.
- · The company has launched a search with a leading executive search firm for the next CFO.
- · Faiz Mohammed has been with Certara since 2018 and has over 25 years of finance experience.
- · The 2026 guidance was initially provided during the first quarter earnings call on May 11, 2026.
17-06-2026
On June 12 and June 15, 2026, NovaBay Pharmaceuticals (now Stablecoin Development Corporation) agreed with two investors, R01 Fund LP and Framework Ventures IV L.P., to amend pre-funded warrants issued in October 2025 by removing exercise restrictions. Both investors exercised their warrants on a cashless basis, receiving an aggregate of 22,614,600 shares of common stock after withholding 24,720 shares as the cashless exercise price. Following this issuance, as of June 15, 2026, total outstanding shares increased to 50,449,780.
- · The warrant amendments removed restrictions on exercisability for the October 2025 Pre-Funded Warrants.
- · The warrants were exercised on a cashless basis, meaning no cash proceeds were received by the company.
- · The total number of shares outstanding increased significantly from an undisclosed pre-exercise count to 50,449,780 shares.
- · The company has changed its name from NovaBay Pharmaceuticals to Stablecoin Development Corporation and its ticker symbol is now SDEV on NYSE American.
17-06-2026
CitroTech Inc. (NYSE American: CITR) announced the resignations of directors Theodore Ralston and Jeffery Pomerantz effective June 12, 2026, with no dispute with management or the Board. The Board appointed Michael Feigin, a seasoned construction and real estate executive, to fill one of the two vacancies, effective June 17, 2026. A search is ongoing for the remaining vacant board position.
- · Michael Feigin, age 66, has over 35 years of leadership experience in construction and real estate.
- · Feigin currently serves as President and CEO of JLA Consulting Group, LLC (since September 2020).
- · He previously served as CEO of MFB Insurance Company, Inc. (Feb 2025 – Feb 2026) and as Executive Vice President and Chief Construction Officer of AvalonBay Communities, Inc. (June 2014 – March 2020).
- · Feigin holds a B.A. in Psychology from Yale University and a J.D. from Brooklyn Law School.
- · Feigin has been appointed to the Board’s audit committee and compensation committee, and will serve as chairman of the Nominating Committee.
- · The remaining vacant board position is still being searched for by the Nominating Committee.
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Material Events SEC 8-K Filings
🇺🇸 More from United States
View all →June 10, 2026
US Pre-Market SEC Filings Roundup — June 10, 2026
US Pre-Market SEC Filings Roundup
June 10, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — June 10, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
June 10, 2026
US Merger & Acquisition SEC Filings — June 10, 2026
US Merger & Acquisition SEC Filings
June 10, 2026
US Corporate Board Director Changes SEC Filings — June 10, 2026
US Corporate Board Director Changes SEC Filings